Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 0 |
|
|||||
| News | - | ||||||
| Day High | Low High |
||||||
| Day Low | |||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Abeona Therapeutics Inc | ABEO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.00 | 0.00% | 3.17 | 20:00:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.17 |
| Trades | Volume | Avg Volume | 52 Week Range |
|---|---|---|---|
| 0 | 0 | - | 2.83 - 9.01 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 3.17 | USD |
Abeona Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 78.53M | 24.77M | - | 4.57M | -54.19M | -2.19 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Abeona Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ABEO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 7.95 | 8.17 | 3.14 | 4.05 | 1,863,784 | -4.78 | -60.13% |
| 1 Month | 7.27 | 8.45 | 3.14 | 4.98 | 661,556 | -4.10 | -56.40% |
| 3 Months | 4.35 | 9.01 | 3.14 | 6.17 | 494,539 | -1.18 | -27.13% |
| 6 Months | 3.99 | 9.01 | 3.14 | 5.73 | 338,042 | -0.82 | -20.55% |
| 1 Year | 3.38 | 9.01 | 2.83 | 5.18 | 241,017 | -0.21 | -6.21% |
| 3 Years | 1.60 | 9.01 | 0.1303 | 1.31 | 895,429 | 1.57 | 98.13% |
| 5 Years | 8.35 | 9.01 | 0.1303 | 1.97 | 1,208,141 | -5.18 | -62.04% |
Abeona Therapeutics Description
| Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. |
